Poly Medicure Ltd's Q4FY25 Quarter Results
- 08 May 2025
Result Summary
- Poly Medicure Ltd reported a 11.9% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 24.6%.
- Its expenses for the quarter were down by 10.1% QoQ and up 24.9% YoY.
- The net profit decreased 19.8% QoQ and increased 16.2% YoY.
- The earnings per share (EPS) of Poly Medicure Ltd stood at 7.1 during Q4FY25.
Financial Statments for Q4FY25
| (₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 393.05 | 446.01 | 315.35 | -11.9% | 24.6% |
Total Expenses | 300.81 | 334.51 | 240.78 | -10.1% | 24.9% |
Profit Before Tax | 92.46 | 111.51 | 74.57 | -17.1% | 24.0% |
Tax | 24.10 | 28.00 | 16.35 | -13.9% | 47.4% |
Profit After Tax | 68.36 | 85.23 | 58.81 | -19.8% | 16.2% |
Earnings Per Share | 7.10 | 8.50 | 6.10 | -16.5% | 16.4% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Poly Medicure Ltd is a prominent player in the healthcare sector, primarily focusing on the manufacturing of medical devices. The company is known for its extensive range of medical products which include infusion therapy, central venous access catheters, anesthesia and respiratory products, among others. Poly Medicure has established a significant presence not only in India but also in international markets. The company has been recognized for its commitment to quality and innovation, often investing in research and development to enhance its product offerings. Recent major developments or specific strategic initiatives for the company are not available in the provided data.
Revenue
In Q4FY25, Poly Medicure Ltd reported a total income of ₹393.05 crores, compared to ₹446.01 crores in Q3FY25 and ₹315.35 crores in Q4FY24. The quarter-over-quarter (QoQ) change in total income was a decrease of 11.9%, whereas, on a year-over-year (YoY) basis, the total income increased by 24.6%. This indicates a substantial growth in revenue when compared to the same quarter of the previous year, despite a decline from the preceding quarter. This performance showcases the company's ability to scale its operations and enhance its revenue generation over the year.
Profitability
For the quarter ending Q4FY25, Poly Medicure Ltd reported a profit before tax of ₹92.46 crores, down from ₹111.51 crores in Q3FY25, but up from ₹74.57 crores in Q4FY24. This reflects a QoQ decline of 17.1% and a YoY growth of 24.0%. The profit after tax stood at ₹68.36 crores in Q4FY25, compared to ₹85.23 crores in the previous quarter and ₹58.81 crores in the same quarter of the prior year. The decline in profit after tax on a QoQ basis was 19.8%, while on a YoY basis, it showed an increase of 16.2%. The earnings per share for Q4FY25 were ₹7.10, representing a decrease of 16.5% QoQ and an increase of 16.4% YoY. These figures indicate the profitability trends for the company, highlighting the variations in earnings over the quarters.
Operating Metrics
The total expenses for Poly Medicure Ltd in Q4FY25 were ₹300.81 crores, compared to ₹334.51 crores in Q3FY25 and ₹240.78 crores in Q4FY24. This denotes a decrease of 10.1% QoQ and an increase of 24.9% YoY. The tax expense for the company in Q4FY25 was ₹24.10 crores, down from ₹28.00 crores in Q3FY25 but up from ₹16.35 crores in Q4FY24, resulting in a QoQ decrease of 13.9% and a YoY increase of 47.4%. These operating metrics provide a detailed view of the company's expenditures and tax liabilities, illustrating the financial dynamics over the specified periods.
